Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Friday.
TCMD has been the subject of several other research reports. Oppenheimer cut Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 5th. B. Riley started coverage on shares of Tactile Systems Technology in a research report on Thursday, September 26th. They set a “buy” rating and a $23.00 price objective for the company. Finally, BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th.
Check Out Our Latest Report on Tactile Systems Technology
Tactile Systems Technology Stock Performance
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of TCMD. Paradigm Capital Management Inc. NY increased its holdings in Tactile Systems Technology by 90.1% in the second quarter. Paradigm Capital Management Inc. NY now owns 1,183,800 shares of the company’s stock valued at $14,135,000 after buying an additional 561,073 shares in the last quarter. Pinnacle Associates Ltd. increased its stake in Tactile Systems Technology by 324.9% in the 2nd quarter. Pinnacle Associates Ltd. now owns 317,024 shares of the company’s stock valued at $3,785,000 after purchasing an additional 242,413 shares in the last quarter. Essex Investment Management Co. LLC acquired a new position in Tactile Systems Technology during the third quarter worth $1,803,000. Los Angeles Capital Management LLC purchased a new stake in Tactile Systems Technology during the second quarter worth $1,187,000. Finally, Federated Hermes Inc. grew its holdings in Tactile Systems Technology by 26.5% in the second quarter. Federated Hermes Inc. now owns 433,660 shares of the company’s stock valued at $5,178,000 after purchasing an additional 90,960 shares during the last quarter. Institutional investors and hedge funds own 83.43% of the company’s stock.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Articles
- Five stocks we like better than Tactile Systems Technology
- Industrial Products Stocks Investing
- Micron Stock Under $100: Seize the AI-Driven Upside
- What is an Earnings Surprise?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.